Stock Market News3 months CorMedix (NASDAQ:CRMD) PT Raised to $17.00 at Truist Financial MarketBeat
Truist Financial boosted their price target on CorMedix from $12.00 to $17.00 and gave the company a “buy” rating in a report on Tuesday.
Nasdaq 100 · Truist Financial Corp (TFC)
X